Skip to content
PubMed This is a summary of 9 peer-reviewed journal articles Updated
Clinical Immunology

The Biology and Diagnosis of ITCH Deficiency

At a Glance

ITCH deficiency is a rare inherited disorder in which changes in both copies of the ITCH gene impair immune regulation. Genetic testing, often including both parents, supports diagnosis, while functional assays and immune-cell blood tests help clarify how the disorder affects a child.

Understanding the biology of ITCH deficiency can be empowering. While the name sounds unusual, it refers to a specific protein that acts as one of the immune system’s most important regulators. Without this working properly, the immune system becomes chronically stuck in an active, inflammatory state [1][2].

The ITCH Gene: Regulating Inflammation

Every cell in your child’s body contains the ITCH gene, which provides instructions for making the ITCH protein. This protein belongs to a group of enzymes called E3 ubiquitin ligases [3].

You can think of the ITCH protein as a quality-control inspector. Its job is to find specific proteins that are causing inflammation and “tag” them with a small molecule called ubiquitin [4]. This tag acts like a regulatory signal, often telling the cell to alter their function or destroy those inflammatory proteins before they can do damage [3][5].

When the ITCH gene has pathogenic variants, this tagging process is impaired. Two major pathways then go out of control:

  • The NF-κB Pathway: This is a master signaling pathway for inflammation. Normally, ITCH helps moderate it. Without proper ITCH function, the pathway stays overly active, leading to a constant flood of inflammatory chemicals (cytokines) throughout the body [2][5].
  • T-Cell Regulation: ITCH specifically helps restrain T-cells, especially those that produce an inflammatory chemical called IL-17 [6]. Without ITCH, these T-cells may become overactive and begin attacking healthy organs like the gut, lungs, and liver [6][1].

How the Diagnosis is Established

Because ITCH deficiency is so rare, it is usually diagnosed through advanced genetic testing. It is classified as a Primary Immune Regulatory Disorder (PIRD)—a group of conditions where the immune system is present but cannot regulate itself correctly [7].

1. Molecular Confirmation

Diagnosis is generally established through advanced genetic testing such as a targeted gene panel, Whole-Exome Sequencing (WES), or genome sequencing. A trio analysis is often performed [8]. In a trio analysis, labs compare the child’s DNA to both parents’ DNA. This identifies that the child inherited two pathogenic or likely pathogenic variants of the ITCH gene (one from each parent), which is the hallmark of an autosomal recessive condition [8][7]. Sometimes testing reveals a “Variant of Uncertain Significance” (VUS) where the lab isn’t immediately sure if it causes the disease.

2. Functional Assays

In some cases, or to clarify a VUS, doctors may perform a functional assay. This involves taking a small sample of cells (like skin or blood cells) and checking if the ITCH protein is actually present or functioning [8]. In established cases with this condition, the ITCH protein is typically severely reduced or absent [9].

Reported Laboratory Findings

When doctors look at a child’s immune system through blood tests, they may see certain abnormalities. These are findings reported in some patients, not universal facts, and they can fluctuate based on age or infection. Common reported findings include:

  • Reduced CD8+ T-cells: These cells are vital for fighting viruses; having too few can increase infection risk [7].
  • Low NK (Natural Killer) Cells: These are the immune system’s first line of defense against infections and abnormal cells [7].
  • Low Regulatory T-cells (Tregs): These are the specific cells meant to calm the immune system down. Their absence may contribute to why the body attacks itself [7][8].
  • Low Memory B-cells: These cells “remember” past infections or vaccines. When they are low, the body may struggle to maintain long-term immunity [7].

By identifying these specific gaps in the immune system, your child’s doctors can better tailor treatments to protect them from infections while trying to calm the overactive parts of their immune response.

Common questions in this guide

What is ITCH deficiency and what does it do to the immune system?
ITCH deficiency is a rare inherited disorder caused by harmful changes in both copies of the ITCH gene. Without enough working ITCH protein, inflammatory signals can remain active, while some immune defenses against infection may be reduced.
How is ITCH deficiency confirmed in a child?
Doctors usually use a genetic panel, whole-exome sequencing, or genome sequencing to look for pathogenic or likely pathogenic variants in ITCH. Testing the child and both parents together, called trio analysis, can show whether the child inherited one variant from each parent.
What does a variant of uncertain significance mean in ITCH testing?
A variant of uncertain significance, or VUS, is a gene change whose effect is not yet clear. It does not by itself confirm ITCH deficiency, so the genetics team may use trio analysis, clinical findings, or a functional assay that checks whether the ITCH protein is present and working.
What is a functional assay for ITCH deficiency?
A functional assay uses a small sample of blood or skin cells to assess whether the ITCH protein is present or working normally. In established cases, the protein is often severely reduced or absent, which can support the genetic findings.
What blood test abnormalities can occur with ITCH deficiency?
Some children have reduced CD8 T cells, natural killer cells, regulatory T cells, or memory B cells. These findings are not present in every child and can vary with age or infection, so an immunology team must interpret them in context.
Why might ITCH deficiency cause both inflammation and infections?
The ITCH protein helps limit inflammatory signaling and supports balanced immune-cell regulation. When it is deficient, the immune system may stay overactive and attack healthy tissues, while reduced numbers of some immune cells can make certain infections more likely.

Get notified when new evidence is published on Syndromic multisystem autoimmune disease due to Itch deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (9)
  1. 1

    Itch regulation of innate and adaptive immune responses in mice and humans.

    Field NS, Moser EK, Oliver PM

    Journal of leukocyte biology 2020; (108(1)):353-362 doi:10.1002/JLB.3MIR0320-272R.

    PMID: 32356405
  2. 2

    Phosphorylation of the E3 ubiquitin protein ligase ITCH diminishes binding to its cognate E2 ubiquitin ligase.

    Perez JM, Chen Y, Xiao TS, Abbott DW

    The Journal of biological chemistry 2018; (293(3)):1100-1105 doi:10.1074/jbc.RA117.000408.

    PMID: 29212706
  3. 3

    Itch WW Domains Inhibit Its E3 Ubiquitin Ligase Activity by Blocking E2-E3 Ligase Trans-thiolation.

    Riling C, Kamadurai H, Kumar S, et al.

    The Journal of biological chemistry 2015; (290(39)):23875-87 doi:10.1074/jbc.M115.649269.

    PMID: 26245901
  4. 4

    Structural basis for the regulatory role of the PPxY motifs in the thioredoxin-interacting protein TXNIP.

    Liu Y, Lau J, Li W, et al.

    The Biochemical journal 2016; (473(2)):179-87 doi:10.1042/BJ20150830.

    PMID: 26527736
  5. 5

    An IκB Kinase-Regulated Feedforward Circuit Prolongs Inflammation.

    Perez JM, Chirieleison SM, Abbott DW

    Cell reports 2015; (12(4)):537-44.

    PMID: 26190110
  6. 6

    Itch inhibits IL-17-mediated colon inflammation and tumorigenesis by ROR-γt ubiquitination.

    Kathania M, Khare P, Zeng M, et al.

    Nature immunology 2016; (17(8)):997-1004 doi:10.1038/ni.3488.

    PMID: 27322655
  7. 7

    ITCH Deficiency Causing Immunodeficiency and Immune Dysregulation.

    Hernández A, Cerda C, María Vinet A, et al.

    Pediatrics 2025; (156(5)) doi:10.1542/peds.2024-069311.

    PMID: 41130596
  8. 8

    Immune Dysregulation in Human ITCH Deficiency Successfully Treated with Hematopoietic Cell Transplantation.

    Patel T, Henrickson SE, Moser EK, et al.

    The journal of allergy and clinical immunology. In practice 2021; (9(7)):2885-2893.e3 doi:10.1016/j.jaip.2021.04.010.

    PMID: 33894394
  9. 9

    ITCH deficiency clinical phenotype expansion and mitochondrial dysfunction.

    Wolfe R, Heiman P, D'Annibale O, et al.

    Molecular genetics and metabolism reports 2022; (33()):100932 doi:10.1016/j.ymgmr.2022.100932.

    PMID: 36338154

This page explains the biology and diagnosis of ITCH deficiency for informational purposes only and does not constitute medical advice. Your child's immunology and genetics team should interpret genetic and immune test results and guide care.